← Back to library
article 2022 7 pages

High Prevalence of Iron Deficiency Exhibited in Internationally Competitive, Non-Professional Female Endurance Athletes–A Case Study

Stacy T. Sims, Kelsi Mackay, Alana Leabeater, Anthea Clarke, Katherine Schofield, Matthew Driller

Journal
International Journal of Environmental Research and Public Health
DOI
10.3390/ijerph192416606
Publication type
Original Research
Population
non-professional female endurance athletes
View on DOI ↗

Abstract

kground: While iron de ciency is commonly discussed in populations of professional female athletes, less is known about highly trained, sub-elite female athletes (e.g., those winning international age-group competitions) who generally have less access to medical and allied health support. Methods: Thirteen non-professional highly trained female endurance athletes provided training diaries and completed a blood test, where iron markers of haemoglobin (Hb), haematocrit (Hct), C-reactive protein (Crp), serum iron, serum ferritin, and transferrin were assessed. Resting metabolic rate (RMR) and body composition using dual-energy X-ray absorptiometry (DXA) were also obtained. Participants were classi ed as iron de cient (ID) if serum ferritin was <30 ug/L serum ferritin. Results: Six of the 13 females were classi ed as ID. Serum iron, ferritin, Hb, Hct, and ferrin were greater in the ID group (p< 0.05). Crp resulted inlargetovery largecorrelations with serum iron (r= 0.72), serum

dual-energy X-ray absorptiometry (DXA) were also obtained. Participants were classi ed as iron de cient (ID) if serum ferritin was <30 ug/L serum ferritin. Results: Six of the 13 females were classi ed as ID. Serum iron, ferritin, Hb, Hct, and ferrin were greater in the ID group (p< 0.05). Crp resulted inlargetovery largecorrelations with serum iron (r= 0.72), serum ferritin (r= 0.66), and transferrin (r= 0.70). Conclusions: In this population of highly trained female athletes, 46% were diagnosed with sub-optimal iron levels, which could have lasting health effects and impair athletic performance. The need for more education and support in non-professional athletes regarding iron de ciency is strongly advised. Keywords:REDs; energy de ciency; anaemia; women's health 1. Introduction Iron de ciency is a common health issue in endurance sports, and it is reported to affect up to 3–11% of male athletes and 15–35% of female athletes [1–3]. Iron loss is exaggerated in athletes due to high training loads and the resulting haemolysis, sweating, and gastrointestinal bleeding, which cause the breakdown of red blood cells and the loss of iron [4]. Female athletes also lose blood during menstruation and, as a result, typically have higher dietary iron needs [5]. In addition to this, hepcidin, an iron-regulating hormone, is upregulated following exercise as part of the acute in ammatory response, which impairs the absorption of iron [6]. Given the importance of power-to-weight-ratio and the perceived bene t of low body mass in endurance sports, the incidence of low energy availability is also somewhat common amongst endurance athletes [7]. While low energy availability can have long-term effects on bone mineral density and general health, having a generally low energy intake in relation to the needs of the individual likely also increases the chance of having insuf cient dietary iron. Given the known in uence of low iron stores on an athlete's capacity to train, perform, and recover [8], monitoring and managing iron de ciency is important in athletic populations. It is particularly important that, not only are athletes consuming suf cient iron in their diet, but that the timing of this intake

chance of having insuf cient dietary iron. Given the known in uence of low iron stores on an athlete's capacity to train, perform, and recover [8], monitoring and managing iron de ciency is important in athletic populations. It is particularly important that, not only are athletes consuming suf cient iron in their diet, but that the timing of this intake is also considered around their training schedule [9,10]. Int. J. Environ. Res. Public Health2022,19, 16606.

Int. J. Environ. Res. Public Health2022,19, 16606 2 of 7 Often, this requires careful consultation with a sports dietitian to ensure that appropriate iron levels can be maintained throughout the training and competition cycle by improving dietary intake of iron or introducing iron supplements, if appropriate [4]. The access to sport dietitians afforded to high-performance athletes allows for thorough education, diagnosis, and treatment of conditions, such as iron de ciency (with or without anaemia). Professional medical support is pertinent in the management of this condition, as incorrect iron supplementation can lead to gastrointestinal discomfort or toxic levels of iron at the liver [4]. While previous research has established the prevalence of iron de ciency in popula- tions of elite female endurance athletes [11], less is known about non-professional, sub-elite female athletes, who often maintain a comparable training volume and performance level to elite athletes. For example, sub-elite and elite female runners complete a similar amount of training sessions and distance per week, but may exhibit differences in training inten- sity [12]. However, sub-elite athletes are less likely to receive dietary counselling than their elite counterparts [13], which may contribute to a poor understanding of the signs and symptoms of iron de ciency and the subsequent health and performance implica- tions [14–16]. Therefore, the aim of the current study was to investigate the prevalence of iron de ciency in a non-professional, highly trained population of female endurance athletes, and to compare iron status to physical characteristics (e.g., body composition), training, blood markers, and other energy intake and expenditure-related variables. It is this population that is of particular interest given the limited support systems in place, despite a generally high volume of training and the potential risk of low energy availability. 2. Materials and Methods 2.1. Participants Thirteen non-professional, highly trained, premenopausal female endurance athletes (mean SD: age: 32 7 y) completed this study. Inclusion criteria included: (a) regular menstrual cycles (24–35 days in length) or using a contraceptive (monophasic pill or intrauterine device) for >6 months before entering the study, (b) representing their country at an international level within the past

Materials and Methods 2.1. Participants Thirteen non-professional, highly trained, premenopausal female endurance athletes (mean SD: age: 32 7 y) completed this study. Inclusion criteria included: (a) regular menstrual cycles (24–35 days in length) or using a contraceptive (monophasic pill or intrauterine device) for >6 months before entering the study, (b) representing their country at an international level within the past three years and currently participating on a regular basis in competitive endurance-sport activity (running, cycling, triathlon), (c) having no current or recent (<3 months) injury or illness, or chronic disease, (d) not being pregnant, (e) not smoking, and (f) not being previously diagnosed as iron de cient or currently taking iron supplements. All participants provided informed written consent, and the study received ethical approval from the Institutions Human Research Ethics Committee. 2.2. Training Diaries Participants' training was recorded over a seven-day period. Online platforms were used to track exercise (TrainingPeaks, Boulder, CO, USA). Total training duration and duration at high intensity (above 80% HR max)were calculated upon analysis of training logs using heart rate-based training impulse (TRIMP). 2.3. Blood Sampling Blood samples were collected following an overnight fast (6:30 p.m. to 8:00 a.m.). All blood samples were obtained via the antecubital vein while in a seated position. After drawing blood, serum and plasma samples were obtained after centrifugation (3000 rpm, 10 min, 4 C) and stored at 80 C until analysed. Cortisol, iron-status variables (haemaglobin, haematocrit, iron, ferritin, transferrin), and a marker of in ammation (Crp) were analysed at the local health-board medical laboratory. Cortisol concentrations were measured by a sensitive and speci c liquid chromatography-tandem mass spectrometry assay, with minor modi cations to improve assay speci city. Athletes were classi ed as iron de cient (ID) if they had a ferritin <30 ug/L. We selected this threshold based on previous recommendations of other authors and clinicians [17–19].

Int. J. Environ. Res. Public Health2022,19, 16606 3 of 7 2.4. Resting Metabolic Rate (RMR) Measured RMR was conducted using the `RMR' function on the TrueOne metabolic analyser (TrueOne 2400, Parvo Medics, Sandy, UT, USA). On the morning of the assess- ment, participants arrived at the laboratory for their scheduled lab appointment (between 0600 and 0830 h) following an overnight fast of >10 h, with participants refraining from exercise, caffeine, and alcohol intake <24 h prior to testing. Participants were instructed to sleep 8 h the night before testing. Participants arrived at the laboratory in a relaxed and rested state and were instructed to perform minimal activity between waking and arrival to the RMR testing session. Upon arrival to the laboratory, participants' height (cm) and body mass (kg; in minimal clothing) were measured before a 5 min passive rest period prior to the RMR assessment. Participants were asked to relax and lie supine on a bed with the head rest set at an incline of 45 during the 20 min assessment period, but to maintain alertness with eyes open. The canopy was then placed over the head, shoulders, and upper chest of the participant to reduce contaminant air entering or expired air escaping during measurement. Flow rate was established at 28 to 30 mL.min 1 within the rst 4 min of the assessment, as per the manufacturer's instructions. Expired air was sampled every 15 s and averaged over 30 s. Data les were exported in Microsoft Excel format for subsequent calculation of RMR (kcal day 1 ) via the Weir formula [20]. RMR was calculated using the average of the nal minute of each 5-min segment of the assessment (4 to 5, 9 to 10, 14 to 15 and 19 to 20 min). The metabolic analyser and RMR protocol implemented in the current study has previously been shown to be reliable in a similar cohort of athletes [21]. 2.5. Body Composition Analysis Body composition and bone health measures were evaluated using whole-body dual- energy X-ray absorptiometry (DXA) scans (GE Prodigy Advance, GE Healthcare, Madison, WI, USA), at a private clinic.

to 20 min). The metabolic analyser and RMR protocol implemented in the current study has previously been shown to be reliable in a similar cohort of athletes [21]. 2.5. Body Composition Analysis Body composition and bone health measures were evaluated using whole-body dual- energy X-ray absorptiometry (DXA) scans (GE Prodigy Advance, GE Healthcare, Madison, WI, USA), at a private clinic. A total-body scan, in standard scan mode using the software enCORE (version 17), was performed and analysed by the same trained technician using standardized protocols. Body composition variables selected included percentage body fat % and bone mineral density (BMD, g/cm 2 ) at the anterior-posterior lumbar spine (L1–L4) and total hip (mean result of two femur measurements). 2.6. Statistical Analysis All data are presented as mean SD unless stated otherwise. Statistical signi cance was set atp< 0.05. Comparison of the ID and non-ID groups was achieved using a Student's unpaired t-test and Cohen's effect sizes (d). The magnitude of effect sizes were assessed with the following thresholds: <0.2,trivial; 0.2–0.6,small; 0.6–1.2,moderate; 1.2–2.0,large; 2.0–4.0,very large; >4.0,extremely large[22]. Pearson's correlations (r) were used to examine associations between variables. The magnitude of correlation between variables was assessed with the following thresholds: <0.10,trivial; 0.10–0.30,small; 0.31–0.50,moderate; 0.51–0.70,large; 0.71–0.90,very large; and 0.91–1.0,almost perfect[23]. 3. Results Of the 13 women who were included in this study, six were classi ed as ID, and seven were classi ed as non-ID [24]. No individual was classi ed as being anaemic (Hb < 12 g L 1 ). Participant anthropometric and training characteristics were similar between groups (Table). Table both groups. Those in the ID group reported elevated Crp (p= 0.0001,d= 3.33 0.93, very large) and transferrin (p= 0.004,d= 1.82 0.91,large). Serum ferritin (p= 0.002, d= 1.97 0.92,large), serum iron (p= 0.011,d= 1.55 0.91,large), haemoglobin (Hb) (p= 0.036,d= 1.24 0.94,large) and haematocrit (Hct) (p= 0.034,d= 1.27 0.92,large) were all signi cantly lower in the ID group when compared with the non-ID group.

0.011,d= 1.55 0.91,large), haemoglobin (Hb) (p= 0.036,d= 1.24 0.94,large) and haematocrit (Hct) (p= 0.034,d= 1.27 0.92,large) were all signi cantly lower in the ID group when compared with the non-ID group.

Int. J. Environ. Res. Public Health2022,19, 16606 4 of 7 Table 1. Participant characteristics ((grouped by iron status, iron de cient (ID) and non-iron de cient (non-ID)) *. ID (n = 6) Non ID (n = 7) Age (yrs) 31 3 34 10 Height (cm) 170.7 2.4 164.2 6.8 Body Mass (kg) 62.6 7.5 58.8 5.7 Body Fat (%) 21.0 6.2 18.8 5.0 BMI 21.6 2.3 21.9 1.7 Training (hrs/wk) 17 5 20 3 * Note: Iron deficiency (ID) defined as <30 ug/L serum ferritin. BMI—body mass index. Data shown as mean SD. Table 2.Comparison of haematological pro les, bone mineral density (BMD), and resting metabolic rate (RMR) in female iron de cient (ID) athletes and non-iron de cient (non-ID) athletes. Marker Normal Ranges ˆ ID (Mean SD) Non ID (Mean SD) p-Value (p) Effect Size (Mean 90% CI) Serum Ferritin (ug/L) 15–200 27.5 2.8 41.0 7.3 0.002 * 1.97 0.92(large) Serum Iron (mmol/L) 11–29 20.5 1.0 25.5 3.4 0.011 * 1.55 0.91(large) Transferrin (g/L) 2.1–3.6 3.9 0.1 3.1 0.6 0.004 * 1.82 0.91(large) Crp (mg/dL) <0.5 2.8 0.5 0.8 0.6 0.0001 * 3.33 0.93 (very large) Cortisol (nmol/L) 251–552 359.3 112.4 320.8 96.4 0.373 0.47 0.95(unclear) Hb (g/L) 120–160 130.5 7.8 143.8 8.4 0.036 * 1.24 0.94(large) Hct (g/L) 0.355–0.449 0.392 0.01 0.430 0.02 0.034 * 1.27 0.92(large) BMD (g/cm 2 ) 1.2 0.1 1.2 0.1 0.70 0.20 0.96(unclear) RMR (kcal) 1581.7 84.2 1670.9 247.9 0.42 0.43 0.91(unclear) * Indicates statistical signi cance (p< 0.05). ˆ Normal ranges, as provided by the clinical laboratory where testing took place. Correlations between variables are shown in Table. Crp was positively correlated with cortisol (r= 0.31) and transferrin (r= 0.70), as well as negatively correlated with serum ferritin (r= 0.66), iron (r = 0.72), and RMR (r= 0.52). Total training duration and high intensity training hadmoderatepositive correlations with cortisol (r= 0.31–0.48) and moderatenegative correlations with RMR (r= 0.66– 0.34). BMD was also associated with amoderatepositive correlation with high intensity training duration (r= 0.68). Table 3. Pearson's correlations between measured blood markers, resting metabolic rate (RMR), and bone mineral density (BMD) in highly

= 0.72), and RMR (r= 0.52). Total training duration and high intensity training hadmoderatepositive correlations with cortisol (r= 0.31–0.48) and moderatenegative correlations with RMR (r= 0.66– 0.34). BMD was also associated with amoderatepositive correlation with high intensity training duration (r= 0.68). Table 3. Pearson's correlations between measured blood markers, resting metabolic rate (RMR), and bone mineral density (BMD) in highly trained, non-professional female athletes. Body Mass % BF RMR Cortisol Serum Ferritin Serum Iron Transferrin Crp BMD Age Hct Hb Training hrs/wk % BF 0.60 ** RMR 0.14 0.09 Cortisol 0.41 * 0.01 0.49 * Serum Ferritin 0.21 0.32 * 0.11 0.06 Serum Iron 0.03 0.21 0.45 * 0.11 0.70 ** Transferrin 0.40 * 0.38 * 0.48 * 0.53 ** 0.23 0.45 * Crp 0.04 0.13 0.52 ** 0.31 * 0.66 ** 0.72 *** 0.70 ** BMD 0.66 ** 0.23 0.12 0.48 * 0.03 0.16 0.16 0.11 Age 0.02 0.18 0.20 0.13 0.37 * 0.31 * 0 0.3 0.37 * Hct 0.24 0.21 0.08 0.15 0.81 *** 0.71 *** 0.21 0.44 * 0.19 0.32 * Hb 0.09 0.13 0.15 0.22 0.75 *** 0.74 *** 0.22 0.5 0.19 0.45 * 0.95 *** Total training duration 0.10 0.23 0.66 ** 0.31 * 0.13 0.04 0.2 0.25 0.06 0.26 0.27 0.27 High- intensity duration 0.30 * 0.13 0.34 * 0.48 * 0.18 0.24 0.15 0.03 0.68 ** 0.06 0.1 0.12 0.70 ** Magnitude of correlation = *moderate, **large, ***very large. BF—body fat, RMR—resting metabolic rate, Crp—C-reactive protein, Hb—haemoglobin, Hct—haematocrit, BMD—bone mineral density. 4. Discussion The current study provides an insight into the health pro les of a group of non- professional, highly trained female endurance athletes. Almost half of this group was

Int. J. Environ. Res. Public Health2022,19, 16606 5 of 7 identi ed as being iron de cient (<30 ug/L serum ferritin), despite having no differences in weekly training hours, or RMR between those classi ed as ID or not. The Crp and transferrin of those with ID were greater than those in the non-ID group. Both groups reported Crp values above what would be considered normal in a clinical setting, while only the ID group had a higher than normal transferrin value. Crp was also found to correlate with a number of iron pro le variables, as well as cortisol. It is important to understand the in uence of high-level training and performance on athletes and how this may present in haematological testing. While within clinical `normal' ranges, the low iron status observed in the ID group would likely impact their training and performance [8,25], and individuals' training status should be taken into consideration by general medical practitioners to ensure appropriate identi cation of iron de ciency in non-professional, highly trained female athletes. The prevalence of ID in this population is similar to previously reported incidences in other populations. Comparing those who were classi ed as ID vs. non-ID, there were no differences in training load volume, anthropometric characteristics, or iron intake. Both groups reported an iron intake below the recommendations for females (18 mg/day) [5], but were similar to other female athlete groups [26,27]. Potentially then, reasons that an individual may become iron de cient within this group of international level, non- professional athletes may be more speci c to the type and timing of iron sources within the diet. Given the complex relationships and interactions between dietary sources of iron, dietary inhibitors, enhancers of iron absorption, and exercise-related hepcidin release, consultation with a dietitian is recommended to navigate this area. While this study uses the athlete-focussed de nition of ID as being <30 ug/L, if as- sessed using clinical reference ranges, none of the athletes in this study would be identi ed as ID. However, within athletic populations a reference range of 30–99 ug/L has been classi ed

hepcidin release, consultation with a dietitian is recommended to navigate this area. While this study uses the athlete-focussed de nition of ID as being <30 ug/L, if as- sessed using clinical reference ranges, none of the athletes in this study would be identi ed as ID. However, within athletic populations a reference range of 30–99 ug/L has been classi ed as `functional iron de ciency', where performance (but not health) may still be affected [28]. Indeed, while the non-ID group did not reach our threshold of ID in this study, the mean ferritin of 40 ug/L is still on the low end and worth continual monitoring. Given these non-professional athletes do not usually have their own medical team, as would be provided to professional athletes, they are required to go through the normal healthcare sys- tem. As such, these athletes could remain undiagnosed in normal healthcare settings based on the clinical guidelines for ID. However, given that the early stages of ID could have a disadvantageous effect on aerobic exercise performance [8], routine monitoring of iron levels in athletes with reference to athlete-speci c ID de nitions is recommended. Indeed, Sim et al. [29] recommended quarterly screening for iron de ciency in endurance athletes, with or without evidence of low energy availability, fatigue, or performance impairment. Both groups in this study had Crp levels above the clinical reference range. However, the ID group had a mean Crp three and a half times higher than the non-ID group. Long term participation in exercise is known to have an anti-in ammatory response, which lowers Crp. Furthermore, a short-term in ammatory response does occur following exer- cise [30]. This short-term elevation can occur up to 48 h post exercise, so while this study controlled for exercise to not occur within 24 h of blood collection, it is possible that Crp was still elevated due to previous training. There is no known in uence of ID on Crp response, so reasons for the differences between groups is currently unknown. Given ferritin is typically elevated during in ammation, higher Crp values may also increase the

Description

The research highlights the health profiles of female endurance athletes regarding iron deficiency.